Technology
INTERSCRIPTS, INC. InterScripts Expands Strategic Nearshore Partnership with Akron Children’s, Extending Support into AI, Cybersecurity, and Clinical Informatics
Published
6 days agoon
By
CHANTILLY, Va., Nov. 10, 2026 /PRNewswire/ — InterScripts, Inc., a healthcare IT services and software company, today announced the continued growth and success of its nearshore delivery partnership with Akron Children’s. Launched in February 2026, the engagement initially focused on Epic application support and has since expanded to include clinical informatics, data analytics, cybersecurity, and artificial intelligence (AI) development.
Delivered through InterScripts’ Medellín, Colombia, center, the partnership provides Akron Children’s access to highly skilled, Epic-certified professionals and specialized healthcare IT talent working in alignment with U.S. business hours. The model combines cost efficiency, bilingual capabilities, and access to Medellín’s deep pool of well-educated technology professionals with the operational integration and accountability required by a leading U.S. health system.
The announcement comes ahead of the CHIME26 Fall Forum, November 11–14, in Aurora, Colorado, where InterScripts will meet with healthcare executives exploring nearshore delivery models for Epic applications, service desk operations, cybersecurity, data engineering, and AI.
From MyChart Support to an Expanded Strategic Partnership
Akron Children’s initially engaged InterScripts to provide bilingual 24/7 MyChart patient support, including assistance with portal access, proxy accounts, and appointment and billing inquiries. Building on that success, the partnership has expanded into additional technology and clinical support functions, including Epic application services, clinical informatics, Databricks and analytics, cybersecurity, and AI development.
The expanded engagement also complements InterScripts’ established relationship with Akron Children’s, which includes legacy Infor application support and BytePad enterprise archiving.
“Healthcare organizations are facing unprecedented workforce challenges. Rising labor costs, supply expenses, and increasing regulatory demands continue to place significant financial and operational pressure on health systems. Our partnership with InterScripts provides Akron Children’s with access to dedicated, highly skilled, and certified professionals working directly from Medellín and fully integrated into our teams.
This strategy is not about replacing our existing workforce. It is about extending our capabilities, addressing specialized staffing gaps, and providing flexibility to accelerate our strategic priorities. Our Medellín colleagues are working side by side with our onshore teams every day across Epic, Databricks, cybersecurity, clinical informatics, and AI development. They are making meaningful contributions to our operations and innovation initiatives, and we are delighted with the value they bring to Akron Children’s.” — Harun Rashid, Chief Digital Information Officer, Akron Children’s
This model enables healthcare organizations to access specialized technology expertise while achieving meaningful cost efficiencies compared with equivalent onshore staffing. Dedicated and fractional resource arrangements also provide the flexibility to scale capabilities around operational demands, application upgrades, and strategic transformation initiatives.
“Nearshore delivery from Medellín gives our clients the economics without the distance. Our professionals are InterScripts employees, credentialed to the same standards as our U.S.-based consultants, and working in the same time zone as the clinicians and technology teams they support.
The fractional resource model is particularly powerful for healthcare CIOs. It creates opportunities to introduce specialized capabilities, such as AI engineers, cybersecurity analysts, and data specialists, within existing budgets rather than postponing important initiatives until the next budget cycle. We believe this model represents an important evolution in how healthcare organizations access and deploy technology talent.” — Raju Togi, Founder, President & CEO, InterScripts, Inc.
Meet InterScripts at CHIME26 Fall Forum
InterScripts will be at the CHIME26 Fall Forum, November 11–14, 2026, at the Gaylord Rockies Resort & Convention Center in Aurora, Colorado. Health system leaders can discuss nearshore capacity for Epic, service desk, cybersecurity, and AI engineering needs. To connect with InterScripts and learn more about its nearshore services, visit www.interscripts.com.
About InterScripts
InterScripts, Inc. is a healthcare and government IT company headquartered in Chantilly, Virginia, with delivery centers in Medellín, Colombia, and Hyderabad, India. Founded in 2017, InterScripts helps health systems retire legacy applications, preserve data integrity, and maintain access to historical records. Its BytePad AI-native intelligent archival platform was reviewed in the KLAS Research Emerging Company Spotlight in February 2026 and named a Notable Vendor in the Gartner Healthcare Data Archival Market Guide in October 2025.
InterScripts operates Epic and Workday Centers of Excellence staffed by Epic-credentialed and more Workday-certified consultants. Its security and quality credentials include HITRUST r2, SOC 2 Type II, ISO 27001:2022, ISO 9001:2015, and CMMI Level 3. The company holds a GSA Multiple Award Schedule. Learn more at www.interscripts.com.
About Akron Children’s
Founded in 1890, Akron Children’s continues to champion pediatric care, medical education, and breakthrough research as Northeast Ohio’s largest independent, nonprofit pediatric healthcare system. Across two main hospital campuses, eight regional health centers, and more than 60 primary and specialty care clinics, their dedicated team of 8,300+ professionals managed a record 1.5 million patient encounters last year alone. Consistently ranked among the nation’s best by U.S. News & World Report, Most Wired and a HIMSS level 7 health system, the system features specialized hubs like the Level I Pediatric Trauma Center and the nationally recognized Paul and Carol David Foundation Burn Institute. Learn more about their compassionate care network at www.akronchildrens.org.
KLAS® is a registered trademark of KLAS Enterprises, LLC. KLAS findings are emerging data, based on samples of 3–5 customer organizations, and may change as the customer base grows. Gartner does not endorse any vendor, product or service depicted in its research publications. Workday, Infor, Lawson, and Kronos are trademarks of their respective owners.
Media Contact:
Adam Terzich, AVP Buyer Services
Email: purchasing@interscripts.com
Phone: 703-635-7676
Web: www.interscripts.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/interscripts-inc-interscripts-expands-strategic-nearshore-partnership-with-akron-childrens-extending-support-into-ai-cybersecurity-and-clinical-informatics-302935248.html
SOURCE InterScripts
You may like
Technology
CSMI Selected by the State of Connecticut to Support Defense CyberSecure Program CMMC Initiatives
Published
13 minutes agoon
November 17, 2026By
SALEM, N.H., Nov. 16, 2026 /PRNewswire/ — CSMI has been selected by the State of Connecticut Office of Manufacturing as an advisory council member for the Defense CyberSecure Program (CT-DCP) to support the development and execution of cybersecurity strategies for Connecticut’s defense and aerospace manufacturing sector.
“CSMI brings an exceptional depth of experience, and a demonstrated understanding of what manufacturers need to navigate the CMMC process, with a particular sensitivity to the needs of small to medium-sized manufacturers,” said Michelle Hall, Director, Office of Manufacturing, Connecticut Economic and Community Development. “Their technical expertise, industry relationships, and commitment to hands-on support makes them an exceptional choice as an advisory council member and trusted service provider. They will be invaluable in helping Connecticut manufacturers strengthen their cybersecurity capabilities, protect sensitive information, and remain competitive in the defense supply chain.”
Through the CT-DCP initiative, CSMI will help manufacturers access funding, training, technical assistance, and qualified cybersecurity providers as they work toward Cybersecurity Maturity Model Certification (CMMC) Level 2. Achieving certification is essential for organizations seeking to maintain eligibility for current and future Department of War contracts.
“Our goal is to ensure that Connecticut suppliers have access to a full complement of tools, guidance, and support, necessary to continue their crucial roles in support of the U.S. Warfighter,” said Christopher Knox, CSMI Senior Program Manager and CT-DCP Board Member.
CSMI currently conducts cybersecurity uplift programs for suppliers throughout the U.S. Defense Industrial Base (DIB), as well as international partners by performing initial gap analysis and all aspects of supplier preparation for final CMMC accreditation. This skillset will help Connecticut manufacturers strengthen cybersecurity practices, develop policies and procedures, safeguard sensitive data, and meet applicable defense contracting requirements. CSMI, as a Managed Services Provider (MSP), provides CMMC compliant network support services which covers a significant number of CMMC Level 2 controls, enhances network security and greatly impacts achievement of CMMC certification.
About CSMI – Founded in 2002, CSMI provides cybersecurity consultancy, training, mission support, and integrated logistics services to the U.S. Government, defense industry, and allied nations. With experience in over 30 countries, 5 continents, afloat, & domestically, CSMI leverages its vast expertise to advance the defense industrial base and U.S. national security interests worldwide.
For more information, visit https://www.csmi.com/ or contact CSMI at information@csmi-mt.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/csmi-selected-by-the-state-of-connecticut-to-support-defense-cybersecure-program-cmmc-initiatives-302941151.html
SOURCE CSMI, LLC
Technology
S&P Global Announces Pricing of Public Offering of $750,000,000 Senior Notes due 2031, $600,000,000 Senior Notes due 2034 and $650,000,000 Senior Notes due 2036
Published
13 minutes agoon
November 17, 2026By
NEW YORK, Nov. 16, 2026 /PRNewswire/ — S&P Global (NYSE: SPGI) (the “Company”) today announced that it has priced a public offering of $750,000,000 aggregate principal amount of 5.600% senior notes due 2031, $600,000,000 aggregate principal amount of 5.800% senior notes due 2034 and $650,000,000 aggregate principal amount of 6.000% senior notes due 2036. BofA Securities, Inc., Goldman Sachs & Co. LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, UBS Securities LLC and Wells Fargo Securities, LLC are acting as joint book-running managers in connection with the offering.
The senior notes due 2031 were priced at 99.841% of their principal amount with a yield to maturity of 5.635%, the senior notes due 2034 were priced at 99.927% of their principal amount with a yield to maturity of 5.814% and the senior notes due 2036 were priced at 99.985% of their principal amount with a yield to maturity of 6.001%. Each series of notes will be an unsecured obligation of the Company and will be guaranteed by its subsidiary, Standard & Poor’s Financial Services LLC. The closing of the sale of the notes is expected to occur on or about November 18, 2026, subject to customary closing conditions.
The Company intends to use the net proceeds from the offering for general corporate purposes, which may include, without limitation, funding of possible acquisitions, repayment, redemption or refinancing of indebtedness, capital expenditures, working capital, satisfaction of other obligations or repurchase of the Company’s outstanding common stock. The Company may temporarily invest the net proceeds of this offering in short-term, liquid investments until they are used for their stated purpose.
The offering is being made pursuant to an effective automatic shelf registration statement on Form S-3 (File No. 333-299594 and 333-299594-01), filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on October 23, 2026, and only by means of a prospectus supplement and accompanying prospectus. A preliminary prospectus supplement and an issuer free writing prospectus relating to the offering have been filed, and a final prospectus supplement relating to the offering will be filed with the SEC. Prospective investors should read the preliminary prospectus supplement, the final prospectus supplement (when available), the accompanying prospectus, the issuer free writing prospectus, and the other documents that the Company has filed with the SEC for more complete information about the Company and the offering. These documents are available at no charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the underwriters or any dealer participating in the offering will arrange to send you the prospectus and the prospectus supplement if you request them by calling BofA Securities, Inc. at 1-800-294-1322 or by emailing dg.prospectus_requests@bofa.com or Goldman Sachs & Co. LLC at 1-866-471-2526 or by emailing prospectus-ny@ny.email.gs.com, Citigroup Global Markets Inc. at 1-800-831-9146, Deutsche Bank Securities Inc. at 800-503-4611 or by emailing prospectus.cpdg@db.com, J.P. Morgan Securities LLC at 212-834-4533, Mizuho Securities USA LLC at 866-271-7403, Morgan Stanley & Co. LLC by emailing prospectus@morganstanley.com, UBS Securities LLC at (833) 481-0269 or Wells Fargo Securities, LLC at 1-800-645-3751 or by emailing wfscustomerservice@wellsfargo.com.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s notes, nor shall there be any sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
Forward-Looking Statements: This press release contains “forward-looking statements,” as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management’s current views concerning future events, trends, contingencies or results, appear at various places in this press release and use words like “anticipate,” “expect,” “future,” “intend,” “plan,” “possible” and similar terms, and future or conditional tense verbs like “could,” “may,” “should,” “will” and “would.” For example, management may use forward-looking statements when addressing topics such as when and whether the offering will be completed and the anticipated use of net proceeds from the offering.
Forward-looking statements are subject to inherent risks and uncertainties. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements include, among other things, market and other conditions, as well as factors described in the Company’s filings with the SEC, including the “Risk Factors” sections in the prospectus and prospectus supplement related to this offering and in the Company’s most recently filed Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and any subsequent document it files with the SEC. Accordingly, the Company cautions readers not to place undue reliance on any forward-looking statements, which speak only as of the dates on which they are made. The Company undertakes no obligation to update or revise any forward-looking statement to reflect events or circumstances arising after the date on which it is made, except as required by applicable law.
About S&P Global
S&P Global (NYSE: SPGI) enables businesses, governments, and individuals with trusted data, expertise and technology to make decisions with conviction. We are Advancing Essential Intelligence through world-leading benchmarks, data, and insights that customers need in order to plan confidently, act decisively, and thrive in a rapidly changing global landscape.
From helping our customers assess new investments across the capital and commodities markets to navigating the energy expansion, acceleration of artificial intelligence, and evolution of public and private markets, we enable the world’s leading organizations to unlock opportunities, solve challenges, and plan for tomorrow – today.
Contact:
Investor Relations:
Mark Grant
Senior Vice President, Investor Relations and Treasurer
Tel: +1 (347) 640-1521
mark.grant@spglobal.com
Media:
Christina Twomey
Chief Communications Officer
Tel: +1 (646) 407-3001
christina.twomey@spglobal.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/sp-global-announces-pricing-of-public-offering-of-750-000-000-senior-notes-due-2031–600-000-000-senior-notes-due-2034-and-650-000-000-senior-notes-due-2036–302941155.html
SOURCE S&P Global
Technology
Texxon Holding Limited Announces Financial Results for Fiscal Year 2026
Published
1 hour agoon
November 16, 2026By
SHANGHAI, Nov. 16, 2026 /PRNewswire/ — Texxon Holding Limited (Nasdaq: NPT) (“Texxon”, together with its subsidiaries, the “Company” or “we”), a leading provider of supply chain management services in the plastics and chemical industries in East China, today announced its financial results for the fiscal year ended June 30, 2026.
Mr. Hui Xu, Chief Executive Officer and Chairman of Texxon, commented: “In fiscal year 2026, amid softening demand for basic chemicals, we proactively optimized our product portfolio and reallocated resources toward our growing plastic particles business to mitigate market headwinds, while continuing to advance our strategic transition toward an integrated business model encompassing supply chain management and manufacturing. These efforts are aimed at diversifying our revenue streams and establishing a more resilient foundation for sustainable growth. Our plastic particles business delivered 14.2% year-over-year revenue growth, supported by stronger market demand across sectors such as automotive, new energy and chemicals, as well as our continued marketing and sales efforts. This growth partially offset the decline in sales of basic chemicals and positions us to capture emerging opportunities in downstream sectors, including automotive and new energy.
“Another significant milestone was the completion of our Henan Polystyrene Factory, which entered production in May 2026. This marks an important step in our transition toward in-house manufacturing, laying the groundwork for greater operational control, enhanced production capabilities, and improved long-term competitiveness. As downstream demand in related industries continues to evolve, we believe the facility will become an important growth driver over the coming years and strengthen our ability to capitalize on improving market conditions.
“Looking ahead, we will focus on transitioning the new facility toward commercial operations by advancing production line commissioning, customer qualification and certification, and order acquisition to support a disciplined ramp-up in capacity while maintaining stringent safety and quality standards. In parallel, we will build on the momentum of our plastic particles business through continued expansion of our customer base, optimization of our product mix, and disciplined cost management.
“While near-term market conditions and the time required to scale up the new facility present challenges, we remain confident in our strategic direction and the long-term potential of our businesses. Through the gradual expansion of our manufacturing capabilities and continued optimization of our business mix, we aim to strengthen operating performance and progressively improve profitability, creating sustainable long-term value for our shareholders.”
Fiscal Year 2026 Financial Summary
Revenue was $484.04 million for fiscal year 2026, compared to $797.15 million for fiscal year 2025.Revenue from sales of basic chemicals was $165.95 million for fiscal year 2026, representing a decrease of 68.4% from $524.64 million for fiscal year 2025.Revenue from sales of plastic particles was $310.98 million for fiscal year 2026, representing an increase of 14.2% from $272.39 million for fiscal year 2025.Gross profit was $1.10 million for fiscal year 2026, compared to $4.70 million for fiscal year 2025.Gross profit margin was 0.2% for fiscal year 2026, compared to 0.6% for fiscal year 2025.Net loss was $8.99 million for fiscal year 2026, compared to $1.45 million for fiscal year 2025.
Net loss attributable to Texxon was $4.86 million for fiscal year 2026, compared to $0.93 million for fiscal year 2025.Basic and diluted losses per share were $0.23 for fiscal year 2026, compared to $0.05 for fiscal year 2025.
Fiscal Year 2026 Financial Results
Revenue
Revenue was $484.04 million for fiscal year 2026, compared to $797.15 million for fiscal year 2025. The decrease primarily reflected lower sales of basic chemicals, partially offset by higher sales of plastic particles and other products.
The Henan Polystyrene Factory remained under construction for substantially all of fiscal year 2026. On May 6, 2026, the Henan Polystyrene Factory was substantially complete and available for use, with trial production commencing since June 2026. During fiscal year 2026, as part of a strategic decision to prioritize the construction, commissioning and ramp-up of the factory, the Company reallocated financial, personnel and management resources from supply chain management business to the factory and intentionally reduced headcount in the supply chain management business. Because the factory had not commenced meaningful commercial production and did not generate manufacturing revenue during fiscal year 2026, this transition contributed to a decrease in revenue during the year.
For the Fiscal Year Ended
June 30,
Change
2026
%
2025
%
$
%
Revenue:
Basic chemicals
$
165,945,854
34.3
%
$
524,640,932
65.8
%
$
(358,695,078)
(68.4)
%
Plastic particles
310,979,692
64.2
%
272,389,920
34.2
%
38,589,772
14.2
%
Other products
7,116,084
1.5
%
117,788
0.0
%
6,998,296
>100.0
%
Total revenue
$
484,041,630
100.0
%
$
797,148,640
100
%
$
(313,107,010)
(39.3)
%
Sales of basic chemicals were $165.95 million for fiscal year 2026, representing a decrease of 68.4% from $524.64 million for fiscal year 2025. The decrease was primarily attributable to reduced resource allocation and a decline in headcount resulting from voluntary employee departures and a slowdown in hiring, as the Company prioritized the construction, commissioning and production ramp-up of the Henan Polystyrene Factory amid softer downstream demand.
Sales of plastic particles were $310.98 million for fiscal year 2026, representing an increase of 14.2% from $272.39 million for fiscal year 2025. The demand for plastic particles increased, driven by the expanded application in new fields such as automotive, new energy and chemical industries. The increase in sales volume of plastic particles was also attributable to the Company’s marketing and sales efforts to meet the growing market needs. Sales of other products were $7.12 million for fiscal year 2026, compared to $0.12 million for fiscal year 2025. The increase was primarily attributable to black metal sales of approximately $7.0 million for fiscal year 2026, while no black metal sales occurred for fiscal year 2025. This small-scale black metal business, which occurred during the transition period, was limited in scale, supported cash flow during the transition, and does not represent a change in the Company’s long-term strategy.
Cost of Sales
Cost of sales was $482.94 million for fiscal year 2026, a decrease of 39.1% from $792.45 million for fiscal year 2025. The decrease in cost of sales is in line with the decrease in revenue.
Gross Profit and Gross Profit Margin
Gross profit was $1.10 million for fiscal year 2026, a decrease of 76.6% from $4.70 million for fiscal year 2025.
Gross profit margin was 0.2% for fiscal year 2026, compared to 0.6% for fiscal year 2025. The gross profit and gross margin decreased primarily due to the Company’s strategic shift toward serving major customers, to whom it offered more competitive pricing. The Company prioritized expanding business scale and strengthening long-term customer relationships over pursuing short-term high-margin transactions. This strategy temporarily reduced gross margin but is expected to enhance customer retention, stabilize cash flows, and support sustainable profitability growth in the long term. In addition, this pricing strategy was intended to establish a customer and distribution base for plastic particles product to be manufactured in Henan Polystyrene Factory.
Operating Expenses
Operating expenses were $9.18 million for fiscal year 2026, representing an increase of 73.2% from $5.30 million for fiscal year 2025.
Selling expenses were $1.83 million for fiscal year 2026, representing a decrease of 24.3% from $2.41 million for fiscal year 2025. The decrease was primarily attributable to a $0.7 million, or 62.3%, decrease in shipping and delivery expenses, generally in line with the decrease in sales volume. This decrease was partially offset by the slight increase in salary and welfare benefits, and business travel and meal expenses.General and administrative expenses were $7.35 million for fiscal year 2026, representing an increase of 154.6% from $2.89 million for fiscal year 2025. The increase was primarily attributable to increases in salary and welfare benefits of approximately $1.9 million, depreciation and amortization of approximately $1.4 million, litigation settlements of approximately $0.4 million, expected credit loss provisions of approximately $0.3 million, office and utility expenses of approximately $0.3 million, and professional service fees of approximately $0.1 million. The increase in salary and welfare benefit expenses was primarily attributable to the addition of higher-compensated senior management and specialized personnel to support the construction, commissioning, and operational ramp-up of the Henan Polystyrene Factory, despite a net decrease in total headcount resulting from organizational streamlining during fiscal year 2026. The increase in depreciation and amortization was primarily due to the substantial completion of the Henan Polystyrene Factory and the commencement of depreciation.
Net Loss
Net loss was $8.99 million for fiscal year 2026, an increase of 518.2% from $1.45 million for fiscal year 2025. Net loss attributable to Texxon was $4.86 million for fiscal year 2026, an increase of 420.6% from $0.93 million for fiscal year 2025.
Basic and Diluted Losses per Share
Basic and diluted losses per share were $0.23 for fiscal year 2026, compared to $0.05 for fiscal year 2025.
Financial Condition
As of June 30, 2026, the Company had cash and cash equivalents of $0.09 million, compared to $2.52 million as of June 30, 2025.
Net cash provided by operating activities was $1.76 million for fiscal year 2026, compared to $2.32 million for fiscal year 2025.
Net cash used in investing activities was $15.03 million for fiscal year 2026, compared to $42.25 million for fiscal year 2025.
Net cash provided by financing activities was $10.39 million for fiscal year 2026, compared to $41.36 million for fiscal year 2025.
About Texxon Holding Limited
Texxon Holding Limited is a leading provider of supply chain management services in the plastics and chemical industries in East China. Through its polystyrene production facility and technology-enabled platform, the Company manufactures and sells polystyrene products and provides a full spectrum of supply chain management services to Chinese Small and Medium-size Enterprises (SME) customers, including procurement, shipping and logistics, payments and fulfillment services. It aspires to build the largest one-stop plastic and chemical raw material supply chain management platform in China, to streamline the complex and labor-intensive raw material procurement process and enhance convenience, cost-effectiveness, and efficiency for customers. Texxon has built a highly scalable distributed software architecture for continuous improvement, and an effective User Experience Design (UED) process to improve the customer experience. In addition, with over a decade of experience, the Company has amassed substantial transaction data, including supplier and customer information, price trends, category-specific price indexes and market demand volume, to analyze price trends and market demands and make informed decisions. For more information, please visit the Company’s website: https://ir.npt-cn.com/.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements, including, but not limited to, the timeline and effects regarding the construction and production of the Henan Polystyrene Factory. These forward-looking statements involve known and unknown risks and uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the fiscal year ended June 30, 2026 filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 16, 2026 and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s latest annual report on Form 20-F and other filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov.
For more information, please contact:
Texxon Holding Limited
Investor Relations Department
Email: ir@totrade.cn
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
TEXXON HOLDING LIMITED AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2026 AND 2025
(EXPRESSED IN U.S. DOLLARS)
June 30,
2026
June 30,
2025
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
$
94,101
$
2,517,577
Restricted cash
2,844
562
Accounts receivable, net of allowance for credit losses of $779,727
and $725,141, respectively
1,095,467
7,522,465
Advances to suppliers
1,418,477
2,675,445
Inventories, net
2,014,539
973,644
Loan to a related party
–
153,554
Prepayments and other current assets
30,433,431
6,918,026
TOTAL CURRENT ASSETS
35,058,859
20,761,273
NON-CURRENT ASSETS:
Property, plant and equipment, net
121,105,735
84,623,119
Intangible assets, net
6,786,552
6,164,781
Prepayments for long-term assets
2,032,625
24,522,149
Deferred offering costs
–
634,978
Operating lease right-of-use assets
121,102
–
Equity investment
132,644
2,261,433
TOTAL NON-CURRENT ASSETS
130,178,658
118,206,460
TOTAL ASSETS
$
165,237,517
$
138,967,733
LIABILITIES
CURRENT LIABILITIES:
Short-term borrowings
$
20,022,998
$
20,624,062
Long-term borrowings, current portion
12,263,267
–
Accounts payable
1,841,898
763,343
Contract liabilities
1,399,956
2,272,179
Accrued expenses and other current liabilities
38,779,414
19,258,940
Operating lease liabilities, current
56,129
–
Due to related parties
3,423,322
29,826,131
TOTAL CURRENT LIABILITIES
77,786,984
72,744,655
NON-CURRENT LIABILITIES:
Long-term borrowings
29,754,531
32,175,020
Operating lease liabilities, non-current
59,814
–
TOTAL LIABILITIES
$
107,601,329
$
104,919,675
Commitments and contingencies (Note 18)
SHAREHOLDERS’ EQUITY (DEFICIT)
Ordinary shares, $0.0001 par value, 450,000,000 shares authorized,
and 22,185,000 issued and outstanding as of June 30, 2026; and
500,000,000 authorized and 20,000,000 issued and outstanding as of
June 30, 2025.
2,219
2,000
Preference shares, $0.0001 par value, 50,000,000 shares authorized,
nil share issued and outstanding as of June 30, 2026; and nil share
authorized, issued and outstanding as of June 30, 2025.
–
–
Additional paid-in capital
18,342,048
777,992
Accumulated deficit
(9,172,009)
(4,316,467)
Accumulated other comprehensive income (loss)
146,406
(275,578)
SHAREHOLDERS’ EQUITY (DEFICIT) ATTRIBUTABLE TO
TEXXON HOLDING LIMITED
9,318,664
(3,812,053)
Non-controlling interests
48,317,524
37,860,111
TOTAL EQUITY
57,636,188
34,048,058
TOTAL LIABILITIES AND EQUITY
$
165,237,517
$
138,967,733
TEXXON HOLDING LIMITED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE FISCAL YEARS ENDED JUNE 30, 2026, 2025 AND 2024
(EXPRESSED IN U.S. DOLLARS)
For the Fiscal Year ended
June 30,
2026
2025
2024
REVENUE
Sales revenue generated from third parties
$
483,849,660
$
797,148,640
$
672,662,697
Sales revenue generated from related parties
191,970
–
–
Total revenue
484,041,630
797,148,640
672,662,697
COST OF SALES
Cost of sales charged by third parties
(482,587,671)
(789,783,093)
(662,621,392)
Cost of sales charged by related parties
–
(2,015,752)
(4,987,246)
Tax and surcharges
(354,679)
(649,245)
(236,983)
Total cost of sales
(482,942,350)
(792,448,090)
(667,845,621)
GROSS PROFIT
1,099,280
4,700,550
4,817,076
OPERATING EXPENSES
Selling and marketing expenses
(1,827,012)
(2,413,149)
(1,990,991)
General and administrative expenses
(7,353,103)
(2,888,047)
(2,166,116)
Total operating expenses
(9,180,115)
(5,301,196)
(4,157,107)
(LOSS) INCOME FROM OPERATIONS
$
(8,080,835)
$
(600,646)
$
659,969
OTHER INCOME (EXPENSES):
Interest expense, net
(820,236)
(408,843)
(470,288)
Interest income – related parties
–
–
34,922
Other income (expense), net
(290,636)
55,680
105,603
Government grants
202,285
216,574
2,896,219
Total other income (expenses), net
(908,587)
(136,589)
2,566,456
INCOME (LOSS) BEFORE PROVISION FOR
INCOME TAXES
(8,989,422)
(737,235)
3,226,425
INCOME TAX EXPENSE
–
(716,897)
(716,782)
NET INCOME (LOSS)
(8,989,422)
(1,454,132)
2,509,643
Less: net income (loss) attributable to non-controlling
interest
(4,133,880)
(521,511)
1,556,083
NET INCOME (LOSS) ATTRIBUTABLE TO
TEXXON HOLDING LIMITED
(4,855,542)
(932,621)
953,560
OTHER COMPREHENSIVE INCOME
Foreign currency translation adjustment
2,902,462
469,036
1,218,751
TOTAL COMPREHENSIVE INCOME (LOSS)
$
(6,086,960)
$
(985,096)
$
3,728,394
Less: comprehensive income (loss) attributable to non-
controlling interests
(1,653,402)
(22,397)
1,528,622
COMPREHENSIVE INCOME (LOSS)
ATTRIBUTABLE TO TEXXON HOLDING
LIMITED
(4,433,558)
(962,699)
2,199,772
BASIC AND DILUTED EARNINGS (LOSS) PER
SHARE:
Net income (loss) attributable to Texxon Holding
Limited per share
Basic and diluted
$
(0.23)
$
(0.05)
$
0.05
Weighted average shares outstanding used in
calculating basic and diluted income per share
Basic and diluted
21,498,658
20,000,000
20,000,000
TEXXON HOLDING LIMITED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE FISCAL YEARS ENDED JUNE 30, 2026, 2025 AND 2024
(EXPRESSED IN U.S. DOLLARS)
For the fiscal year ended
June 30,
2026
2025
2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)
$
(8,989,422)
$
(1,454,132)
$
2,509,643
Adjustments to reconcile net income (loss) to net
cash provided by (used in) operating activities:
Depreciation and amortization
1,628,816
288,072
332,728
Non-cash operating lease expenses
55,047
–
–
Interest income from a related party
–
–
(34,922)
Allowance (recovery) for credit losses
1,023,150
720,054
(1,385)
Inventory write-down
334,352
–
–
Loss on disposal of equity investment
199,524
–
–
Changes in operating assets and liabilities:
Accounts receivable
5,200,052
2,986,453
(7,512,856)
Notes receivable
–
1,899,032
(1,896,246)
Inventories
(1,291,465)
(86,676)
(466,902)
Advances to suppliers
1,363,266
(1,011,848)
147,725
Prepayments and other current assets
(8,118,632)
(3,315,341)
(559,757)
Notes payable
–
–
(13,828,757)
Accounts payable
1,005,030
(546,002)
(10,429,603)
Accrued expenses and other current liabilities
10,380,455
1,231,325
1,902,256
Contract liabilities
(969,136)
1,614,022
(957,134)
Change in lease liabilities – operating lease
(60,051)
–
–
NET CASH PROVIDED BY (USED IN)
OPERATING ACTIVITIES
1,760,986
2,324,959
(30,795,210)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of plant, property and equipment
(14,768,868)
(45,103,546)
(33,338,925)
Disposal of equity investments
2,116,747
–
–
Purchase of intangible assets
(500,000)
–
(6,805)
Payments made for loans to related parties
–
–
(152,253)
Prepayment made for software
(2,032,625)
–
–
Government grant received in connection with the
construction of plant, property and equipment
–
2,853,622
–
Loan repayment from a related party
157,278
–
22,478,306
NET CASH USED IN INVESTING ACTIVITIES
(15,027,468)
(42,249,924)
(11,019,677)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from short-term borrowings
47,250,830
154,521,737
141,956,726
Proceeds from long-term borrowings
7,551,002
30,105,666
–
Repayment of short-term borrowings
(47,511,932)
(154,473,136)
(127,367,676)
Capital contribution from non-controlling interests
12,080,405
2,647,556
9,254,357
Financing cost paid for the syndicated loan
–
(1,011,893)
–
Withdrawal of capital by non-controlling interests
–
–
(1,460,814)
Payments made to shareholders to acquire Net Plastic
Technology for the Reorganization
–
–
(12,226,342)
Proceeds from related parties
–
9,663,775
19,747,892
Repayment to related parties
(27,228,323)
–
–
Net proceeds from initial public offering
9,458,594
–
–
Proceeds from return of capital previously withdrawn
in connection with the Reorganization
9,008,782
–
–
Payments made for deferred offering costs
(220,261)
(93,243)
(539,639)
NET CASH PROVIDED BY FINANCING
ACTIVITIES
10,389,097
41,360,462
29,364,504
EFFECT OF EXCHANGE RATE CHANGE ON CASH,
CASH EQUIVALENTS AND
RESTRICTED CASH
456,191
24,642
1,326,240
NET CHANGE IN CASH, CASH EQUIVALENTS
AND RESTRICTED CASH
(2,421,194)
1,460,139
(11,124,143)
CASH, CASH EQUIVALENTS AND RESTRICTED
CASH – beginning of year
2,518,139
1,058,000
12,182,143
CASH, CASH EQUIVALENTS AND RESTRICTED
CASH – end of year
$
96,945
$
2,518,139
$
1,058,000
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Cash paid for income taxes
–
(10,202)
(432)
Cash paid for interest, net of amounts capitalized
(363,642)
(1,942,702)
(549,534)
Cash received from interest income
–
1,845
226,831
SUPPLEMENTAL DISCLOSURE OF NON-CASH
ACTIVITIES:
Payable related to purchase of property, plant, and
equipment
3,739,316
5,318,449
6,069,298
Prepayment for long-term assets transferred to property,
plant and equipment
25,714,706
19,262,697
4,516,656
Right-of-use assets obtained in exchange for lease
liabilities
169,511
–
–
Interest receivable accrued related to loan to a related
party
–
–
34,922
Cash and cash equivalents
94,101
2,517,577
272,895
Restricted cash
2,844
562
785,105
Total cash, cash equivalents and restricted cash
$
96,945
$
2,518,139
$
1,058,000
View original content:https://www.prnewswire.com/news-releases/texxon-holding-limited-announces-financial-results-for-fiscal-year-2026-302941085.html
SOURCE Texxon Holding Limited
CSMI Selected by the State of Connecticut to Support Defense CyberSecure Program CMMC Initiatives
S&P Global Announces Pricing of Public Offering of $750,000,000 Senior Notes due 2031, $600,000,000 Senior Notes due 2034 and $650,000,000 Senior Notes due 2036
Nvidia shares fall 4% as board reportedly rules out Huang return
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoDomoAI Launches InkoAI Agent – One Sentence to Ready-to-Post Video
-
Technology5 days agoLG ELECTRONICS’ PRISM AI WINS THREE HONORS AT 2026 AMEC AWARDS
-
Near Videos4 days agoIllia Polosukhin on NEAR’s answer to Big Tech AI
-
Coin Market5 days agoSouth Korea to permit crypto withdrawal freezes during hacking threats
-
Near Videos3 days agoIllia Polosukhin on NEAR as encrypted Ethereum
-
Technology3 days agoInnovative Immunology Biotech Windward Bio Lists on Nasdaq
-
Coin Market4 days agoGemini’s quarterly retail trading volume sinks to 3-year low
-
Coin Market4 days agoDOJ moves to seize $1.2B from Binance hack, disrupts FaceStealer scam
